Full Post Doc/Researcher Profile

Uma Chandran, PhD, MSIS

Recent Publications

The caBIG® Life Science Business Architecture Model. Lauren Becnel Boyd; Scott P. Hunicke-Smith; Grace A. Stafford; Elaine T. Freund; Michele Ehlman; Uma Chandran; Robert Dennis; Anna T. Fernandez; Stephen Goldstein; David Steffen; Benjamin Tycko; Juli D. Klemm  Bioinformatics 2011; doi: 10.1093/bioinformatics/btr141
 
Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma.
Bartholow TL, Chandran UR, Becich MJ, Parwani AV. Diagn Pathol. 2011 Jan 21;6(1):12. [E pub ahead of print]
 
Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
Tanner L Bartholow, Uma R Chandran, Michael J Becich and Anil V Parwani
BMC Clinical Pathology 2011, 11:1doi:10.1186/1472-6890-11-1 Published: 14 January 2011
 
Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.  Chang G, Xu S, Dhir R, Chandran U, O'Keefe DS, Greenberg NM, Gingrich JR.
Clin Cancer Res. 2010 Nov 15;16(22):5390-401. Epub 2010 Nov 9.PMID: 21062931 [PubMed - in process]
Michael J. Becich, MD, PhD